Yüklüyor......
An ‘off-the-shelf’ fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies
T cell malignancies represent a group of hematologic cancers with high rates of relapse and mortality in patients for whom no effective targeted therapies exist. The shared expression of target antigens between chimeric antigen receptor (CAR) T cells and malignant T cells has limited the development...
Kaydedildi:
| Yayımlandı: | Leukemia |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6102094/ https://ncbi.nlm.nih.gov/pubmed/29483708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41375-018-0065-5 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|